LSL Pharma Group Inc. (V:LSL)
Business Focus: Pharmaceuticals (NEC)
May 30, 2024 07:00 am ET
LSL Pharma Group Reports Record Revenues and Margins for the First Quarter 2024
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter of fiscal year 2024 ended on March 31, 2024. “During the quarter,...
May 22, 2024 07:00 am ET
LSL Pharma Group Announces Listing of Convertible Redeemable Debentures on the TSXV
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce that the Convertible Unsecured Redeemable Debentures (the "Debentures") issued pursuant to a $3.288 million...
May 06, 2024 07:00 am ET
LSL Pharma Group Enters Into Binding Agreement to Acquire Quebec Competitor
LSL PHARMA GROUP INC. (TSXV: LSL) ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has entered into a binding Letter of Intent ("LOI") to acquire profitable privately held, Quebec-based...
Apr 30, 2024 07:00 am ET
LSL Pharma Group Reports Its Fourth Quarter and Year-End 2023 Results and Highlights
LSL PHARMA GROUP INC. (TSXV: LSL) (the “Corporation” or “LSL Pharma”), a Canadian integrated pharmaceutical company, today reported its financial results for the year-ended December 31, 2023. “During the year, LSL Pharma has completed an...
Apr 24, 2024 07:00 am ET
LSL Pharma Group Secures $3.8 Million as the Second and Final Tranche of Its Private Placement of Units
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the second and final tranche of its private placement financing of Units (as defined hereafter) for $3.8 million...
Apr 23, 2024 07:00 am ET
LSL Pharma Group Announces the Addition of New Members to Its Board of Directors
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the appointment of Diane Beaudry and Mario Paradis to its Board of Directors. "It is my pleasure and privilege to...
Apr 11, 2024 07:00 am ET
LSL Pharma Group Announces the Upsizing of Its Private Placement From $3.5 Million to $7.5 Million
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the upsizing of its previously communicated non-brokered private placement financing of Units (as defined...
Apr 09, 2024 07:00 am ET
LSL Pharma Group Announces its Participation in the "2024 Bloom Burton & Co. Healthcare Investor Conference "
LSL PHARMA GROUP INC (TSXV: LSL) (the "Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, announced today that it will participate in the Bloom Burton & Co. Healthcare Investor Conference. Mr. Roberge, President and CEO, will...
Mar 19, 2024 07:00 am ET
LSL Pharma Group Secures $6.44 Million as the First Closing of Concurrent Non-Brokered Private Placements
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma"), a Canadian integrated pharmaceutical company, today announced the closing on March 18, 2024 of non-brokered private placements for $6.44 million representing the first closing...
Mar 07, 2024 07:00 am ET
LSL Pharma Group Announces a Combination of Private Placements for Maximum Aggregate Gross Proceeds of $8 Million
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today announced the launch of a non-brokered private placement financing of Units (as defined hereinafter) for minimum gross...
Jan 08, 2024 07:00 am ET
LSL Pharma Group Announces an Extension of its Convertible Debentures Offering
LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces that it extends until February 7, 2024 its brokered private placement through the issuance of unsecured convertible...
Dec 08, 2023 12:41 pm ET
LSL Pharma Group Announces Closing of Second Tranche of Convertible Debentures Offering
LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, is pleased to announce that the Company has closed the second tranche of its brokered private placement (the “Offering”)...
Dec 04, 2023 07:30 am ET
LSL Pharma Group Appoints Luc Mainville as Chief Financial Officer
LSL PHARMA GROUP INC (TSXV: LSL) ("the Company" or "LSL Pharma "), a Canadian integrated pharmaceutical company, is pleased to announce the appointment of Mr. Luc Mainville as Senior Vice President and Chief Financial Officer effective December 4,...
Nov 29, 2023 07:00 am ET
LSL Pharma Group Announces its Results for the Third Quarter of Fiscal 2023
LSL PHARMA GROUP INC (TSXV: LSL) - LSL Pharma Group Inc. ("the Company" or "LSL Pharma Group"), a Canadian integrated pharmaceutical company, has announced its financial results for the third quarter ended September 30, 2023. The Company's MD&A and...
Nov 01, 2023 11:50 am ET
LSL Pharma Group Announces Closing of First Tranche of Convertible Debentures Offering
LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, is pleased to announce that further to its press release of September 21, 2023, the Company has closed the first tranche of its...
Oct 25, 2023 07:00 am ET
Groupe LSL Pharma Announces New Orders with an Annual Revenue Potential in Excess of $2.6 Million
Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announces today that its subsidiary LSL Laboratory (“LSL”) has received new orders for natural health products. Unless...
Oct 18, 2023 07:00 am ET
LSL Pharma Group Announces Exclusive Distribution Agreement With Fera Pharmaceuticals to Alleviate Drug Shortage in U.S. Hospitals
LSL Pharma Group Inc. (TSXV: LSL), (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced today that it has entered into an exclusive agreement with Fera Pharmaceuticals, LLC (“Fera”), a U.S. specialty...
Oct 06, 2023 07:30 am ET
LSL Pharma Group Engages Paradox as Investor Relations Services Provider
LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, is pleased to announce that it has retained on October 5, 2023 the services of Paradox Public Relations Inc. (“Paradox”) to...
Sep 21, 2023 11:23 am ET
LSL Pharma Group Announces Brokered Private Placement of Convertible Debentures of Up to $4,000,000
LSL Pharma Group Inc. (TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced today that it has entered into an agreement with iA Capital Markets as the sole agent and sole bookrunner ("Agent"),...
Aug 29, 2023 10:55 pm ET
LSLPharma Group Announces Its Second Quarter Results
Groupe LSL Pharma Inc. (TSXV: LSL) – (“the Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, announced its financial results for the second quarter ended June 30, 2023. The Company’s Management's Discussion and Analysis...
Jun 20, 2023 05:54 pm ET
Groupe LSL Pharma Update on Increased Production Capacity and Anticipated Sales Growth
GROUPE LSL PHARMA INC (TSXV: LSL) - Groupe LSL Pharma Inc. ("the Company" or " LSL Pharma Group "), a Canadian integrated pharmaceutical company, is pleased to announce that its total annual production capacity will be increased by approximately...
Mar 14, 2023 08:00 am ET
LSL Group Closes a Complementary and Final Private Placement of $145,000.10 to Its Reverse Takeover
LSL PHARMA GROUP INC. (TSXV : LSL) – LSL Pharma Group Inc. (the “Corporation” or “LSL Group”) is pleased to announce the closing of a complementary private placement for gross proceeds of $145,000.10 (the “Private Placement”) by the issuance of...
Feb 27, 2023 08:00 am ET
Closing of the Reverse Takeover Transaction With Laboratoire LSL Inc.
LSL PHARMA GROUP INC. (TSXV : LSL) – LSL Pharma Group Inc. (the “Corporation” or “LSL Group”) (formerly Îledor Exploration Corporation) is pleased to announce the results of its annual and special meeting of shareholders held on January 31, 2023...
Nov 29, 2017 10:43 am ET
Liberty Silver Announces Name Change to Bunker Hill Mining Corp. and New Symbol “BNKR”
TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Liberty Silver Corp. (the “Company”) (CSE:LSL) is pleased to announce that effective November 28, 2017 the Canadian Securities Exchange (the “CSE”) has approved the name of the Company’s name change to...
Nov 20, 2017 05:15 pm ET
Liberty Silver Announces Upsize to C$8 Million of Previously Announced Private Placement
Not for distribution to United States Newswire Services or for dissemination in the United States
Nov 15, 2017 07:30 am ET
Liberty Silver Provides an Update on Its Progress Regarding the Bunker Hill Zinc, Lead, Silver Mine
TORONTO, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Liberty Silver Corp. (CSE:LSL) (“Liberty” or the “Company”) is pleased to provide an update on its progress regarding the Bunker Hill Zinc, Lead, and Silver Mine (“Bunker Hill”). The Bunker Hill...
Oct 25, 2017 04:00 pm ET
Liberty Silver Announces Private Placement of Up to C$5 Million
Not for distribution to United States Newswire Services or for dissemination in the United States...
May 23, 2017 06:02 pm ET
Liberty Silver Corp. Amends Letter of Intent to Acquire Bunker Hill Mine
Liberty Silver Corp. ("Liberty" or the "Company") (CSE:LSL) is pleased to announce that, following discussions with Placer Mining Corp. ("Placer" or the "Vendor"), the current owner of the Bunker Hill Mine, that have occurred over the last several...
May 23, 2017 06:02 pm ET
Liberty Silver Corp. Amends Letter of Intent to Acquire Bunker Hill Mine
Liberty Silver Corp. ("Liberty" or the "Company") (CSE: LSL) is pleased to announce that, following discussions with Placer Mining Corp. ("Placer" or the "Vendor"), the current owner of the Bunker Hill Mine, that have occurred over the last several days, Placer and Liberty have elected to undertake several modifications to the Letter of Intent that exists between the Parties.
May 19, 2017 01:15 pm ET
IIROC Trade Resumption - LSL
VANCOUVER, May 19, 2017 /CNW/ - Trading resumes in:
May 19, 2017 11:40 am ET
Liberty Silver Resumes Trading on the Canadian Securities Exchange and Announces Management Changes
Liberty Silver Corp. (CSE: LSL)(CSE: LSL.CN)(CNSX: LSL) ("Liberty" or the "Company") announced today that it has commenced trading on the Canadian Securities Exchange this morning under the trading symbol 'LSL'.
May 19, 2017 11:39 am ET
Liberty Silver Resumes Trading on the Canadian Securities Exchange and Announces Management Changes
Liberty Silver Corp. (CSE:LSL)(CSE:LSL.CN)(CNSX:LSL) ("Liberty" or the "Company") announced today that it has commenced trading on the Canadian Securities Exchange this morning under the trading symbol 'LSL'.
"We are extremely gratified to...
May 19, 2017 09:53 am ET
IIROC Trading Halt - LSL
VANCOUVER, May 19, 2017 /CNW/ - The following issues have been halted by IIROC:
May 19, 2017 08:37 am ET
IIROC Trading Halt - LSL
TORONTO, May 19, 2017 /CNW/ - The following issues have been halted by IIROC:
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.